首页 | 本学科首页   官方微博 | 高级检索  
     

安络化纤丸联合恩替卡韦治疗慢性乙型肝炎肝纤维化疗效观察
引用本文:戚合德,杨阳,龚守军. 安络化纤丸联合恩替卡韦治疗慢性乙型肝炎肝纤维化疗效观察[J]. 中国现代医生, 2008, 46(11): 88-89
作者姓名:戚合德  杨阳  龚守军
作者单位:1. 武警上海总队机关门诊部,上海,200336
2. 武警上海总队医院传染科,上海,201103
摘    要:
目的评价安络化纤丸联合恩替卡韦治疗慢性乙型肝炎肝纤维化的疗效。方法采用安络化纤丸联合恩替卡韦治疗慢性乙型肝炎30例,并与单用恩替卡韦治疗28例随机对照观察1年。结果联合治疗组治疗后患者各项肝纤维化指标下降幅度明显大于单用恩替卡韦治疗组(P〈0.01)。结论联合用药更有利于阻断或逆转肝纤维化的形成和发展。

关 键 词:乙型肝炎  肝纤维化  恩替卡韦  安络化纤丸  治疗
文章编号:1673-9701(2008)11-88-02
修稿时间:2007-11-05

Clinical Observation on the Effect of Anluohuaxlan Capsule Combined with Entecavir in Treating Chronic Hepatitis B with Liver Fibrosis
QI Hede,YANG Yang,GONG Shoujun. Clinical Observation on the Effect of Anluohuaxlan Capsule Combined with Entecavir in Treating Chronic Hepatitis B with Liver Fibrosis[J]. , 2008, 46(11): 88-89
Authors:QI Hede  YANG Yang  GONG Shoujun
Affiliation:QI Hede YANG Yan GONG Shoujun(1.Outpatient Department of Shanghai Corps Organization, Chinese People's Armed Police Forces,Shanghal 200336; 2.Department of Infectious Diseases, Shanghai Corps Hospital, Chinese People' s Armed Police Forces, Shanghai 201103)
Abstract:
Objective To assess the therapeutic effect of anluohuaxian capsule combined with entecavir in treating chronic hepatitis B with Liver fibrosis. Methods Thirty patients with chronic hepatitis B in treatment group were treated with anluohuaxian capsule and entecavir, while twenty-eight patients in control group just received entecavir. The therapeutic duration in both groups was one years. Results In the treatment group,the decreased range of liver fibrosis index was much more significant than that of the control group(P〈 0.01 ). Conclusion Combined medicine has more advantages for prevetning or reversing the formation and development of liver fibrosis.
Keywords:Chronic hepatitis B  Liver fibrosis  Anluohuaxian capsule  Entecavir  Treatment
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号